Cephalothin kinetics: before, during, and after cardiopulmonary bypass surgery

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Anesthesiology

Background:

• Cardiopulmonary bypass surgery significantly alters physiological conditions.
• Understanding drug disposition during surgery is crucial for patient care.
• Cephalothin is an antibiotic commonly used in surgical settings.

Purpose of the Study:

• To investigate the pharmacokinetic profile of cephalothin before, during, and after cardiopulmonary bypass surgery.
• To determine the impact of cardiopulmonary bypass and general anesthesia on cephalothin clearance and elimination.
• To characterize the formation and kinetics of the deacetylcephalothin metabolite.

Main Methods:

• Kinetic analysis of cephalothin in 5 patients.
• Sampling at three time points: pre-operation (PREOP), during surgery (SURG), and post-operation (POSTOP).
• Measurement of renal and total body clearance, and metabolite levels.

Main Results:

• Renal clearance of cephalothin was significantly lower during surgery (94 ml/min) compared to post-operation (248 ml/min).
• Total body clearance was reduced during the surgical procedure (p < 0.01) primarily due to decreased metabolic clearance.
• Cephalothin elimination was reduced throughout the surgical period, suggesting a significant influence of general anesthesia on drug disposition.
• The metabolite deacetylcephalothin formed rapidly and exhibited parallel kinetic behavior to the parent drug.

Conclusions:

• General anesthesia and cardiopulmonary bypass surgery significantly impact cephalothin pharmacokinetics.
• Reduced metabolic clearance is the main factor contributing to decreased cephalothin elimination during surgery.
• The formation and kinetics of deacetylcephalothin mirror those of cephalothin, suggesting coordinated metabolic pathways.